Hisamitsu Pharmaceutical Co.
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Hisamitsu Pharmaceutical Co. sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Hisamitsu Pharmaceutical Co.: 7 sponsored US clinical trials, none currently recruiting.
Hisamitsu Pharmaceutical Co. sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 5 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Ankle Sprain, with 1 trials.
Upper-quartile sponsor footprint
Hisamitsu Pharmaceutical Co. sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail
NCT01400594
FS-67 in the Treatment of Pediatric Patients With Ankle Sprain
NCT01037816
HKT-500 in the Treatment of Adult Patients With Ankle Sprain
NCT00927641
HKT-500 in Adult Patients With Shoulder Pain
NCT00680472
HKT-500 in Adult Patients With Ankle Sprain
NCT00680784
HKT-500-US12 In Adult Patients With OA Knee Pain
NCT00647231
HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain
NCT00792727
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Therapeutic Areas
How the Hisamitsu Pharmaceutical Co. archive is shaped
7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).
Phase mix: 5 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Ankle Sprain (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Hisamitsu Pharmaceutical Co.: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Hisamitsu Pharmaceutical Co. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Hisamitsu Pharmaceutical Co. page
7 registered trials is a research-attention snapshot, not an endorsement of Hisamitsu Pharmaceutical Co. or any single study.
- None of Hisamitsu Pharmaceutical Co.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Ankle Sprain is the condition Hisamitsu Pharmaceutical Co. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ankle Sprain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hisamitsu Pharmaceutical Co. pipeline card: 7 registered trials from official public datasets.Report a data error.